Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 947

1.

A causal modelling framework for reference-based imputation and tipping point analysis in clinical trials with quantitative outcome.

White IR, Joseph R, Best N.

J Biopharm Stat. 2019 Nov 12:1-17. doi: 10.1080/10543406.2019.1684308. [Epub ahead of print]

PMID:
31718423
2.

Lipid lowering and Alzheimer's disease risk: a Mendelian randomization study.

Williams DM, Finan C, Schmidt AF, Burgess S, Hingorani AD.

Ann Neurol. 2019 Nov 12. doi: 10.1002/ana.25642. [Epub ahead of print]

PMID:
31714636
3.

Multivariate Genome-Wide Association Analysis of a Cytokine Network Reveals Variants with Widespread Immune, Haematological, and Cardiometabolic Pleiotropy.

Nath AP, Ritchie SC, Grinberg NF, Tang HH, Huang QQ, Teo SM, Ahola-Olli AV, Würtz P, Havulinna AS, Santalahti K, Pitkänen N, Lehtimäki T, Kähönen M, Lyytikäinen LP, Raitoharju E, Seppälä I, Sarin AP, Ripatti S, Palotie A, Perola M, Viikari JS, Jalkanen S, Maksimow M, Salmi M, Wallace C, Raitakari OT, Salomaa V, Abraham G, Kettunen J, Inouye M.

Am J Hum Genet. 2019 Oct 30. pii: S0002-9297(19)30389-1. doi: 10.1016/j.ajhg.2019.10.001. [Epub ahead of print]

PMID:
31679650
4.

Overestimated treatment effects in randomised phase II trials: What's up doctor?

Michiels S, Wason J.

Eur J Cancer. 2019 Oct 31;123:116-117. doi: 10.1016/j.ejca.2019.09.023. [Epub ahead of print] No abstract available.

PMID:
31678769
5.

Blood-based systems biology biomarkers for next-generation clinical trials in Alzheimer's disease
.

Hampel H, Vergallo A, Afshar M, Akman-Anderson L, Arenas J, Benda N, Batrla R, Broich K, Caraci F, Cuello AC, Emanuele E, Haberkamp M, Kiddle SJ, Lucía A, Mapstone M, Verdooner SR, Woodcock J, Lista S.

Dialogues Clin Neurosci. 2019;21(2):177-191.

6.

Progression of conventional cardiovascular risk factors and vascular disease risk in individuals: insights from the PROG-IMT consortium.

Bahls M, Lorenz MW, Dörr M, Gao L, Kitagawa K, Tuomainen TP, Agewall S, Berenson G, Catapano AL, Norata GD, Bots ML, van Gilst W, Asselbergs FW, Brouwers FP, Uthoff H, Sander D, Poppert H, Hecht Olsen M, Empana JP, Schminke U, Baldassarre D, Veglia F, Franco OH, Kavousi M, de Groot E, Mathiesen EB, Grigore L, Polak JF, Rundek T, Stehouwer CD, Skilton MR, Hatzitolios AI, Savopoulos C, Ntaios G, Plichart M, McLachlan S, Lind L, Willeit P, Steinmetz H, Desvarieux M, Ikram MA, Johnsen SH, Schmidt C, Willeit J, Ducimetiere P, Price JF, Bergström G, Kauhanen J, Kiechl S, Sitzer M, Bickel H, Sacco RL, Hofman A, Völzke H, Thompson SG; PROG-IMT Study Group.

Eur J Prev Cardiol. 2019 Oct 16:2047487319877078. doi: 10.1177/2047487319877078. [Epub ahead of print]

7.

Economic evaluation of damage accrual in an international SLE inception cohort using a multi-state model approach.

Barber MRW, Hanly JG, Su L, Urowitz MB, St Pierre Y, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, Dooley MA, Fortin PR, Gladman DD, Sanchez-Guerrero J, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Mackay M, Alarcón GS, Manzi S, Nived O, Jönsen A, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Farewell V, Stoll T, Buyon J, Clarke AE.

Arthritis Care Res (Hoboken). 2019 Oct 14. doi: 10.1002/acr.24092. [Epub ahead of print]

PMID:
31609532
8.

GPseudoClust: deconvolution of shared pseudo-profiles at single-cell resolution.

Strauss ME, Kirk PDW, Reid JE, Wernisch L.

Bioinformatics. 2019 Oct 14. pii: btz778. doi: 10.1093/bioinformatics/btz778. [Epub ahead of print]

PMID:
31608923
9.

Investigating populations via penguins and their poo!

Bonnett LJ, White SR.

Teach Stat. 2019 Fall;41(3):101-105. doi: 10.1111/test.12195. Epub 2019 Feb 27.

10.

Adjusting for time-varying confounders in survival analysis using structural nested cumulative survival time models.

Seaman S, Dukes O, Keogh R, Vansteelandt S.

Biometrics. 2019 Sep 28. doi: 10.1111/biom.13158. [Epub ahead of print]

PMID:
31562652
11.

Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) - a natural experiment (protocol).

Hickman M, Dillon JF, Elliott L, De Angelis D, Vickerman P, Foster G, Donnan P, Eriksen A, Flowers P, Goldberg D, Hollingworth W, Ijaz S, Liddell D, Mandal S, Martin N, Beer LJZ, Drysdale K, Fraser H, Glass R, Graham L, Gunson RN, Hamilton E, Harris H, Harris M, Harris R, Heinsbroek E, Hope V, Horwood J, Inglis SK, Innes H, Lane A, Meadows J, McAuley A, Metcalfe C, Migchelsen S, Murray A, Myring G, Palmateer NE, Presanis A, Radley A, Ramsay M, Samartsidis P, Simmons R, Sinka K, Vojt G, Ward Z, Whiteley D, Yeung A, Hutchinson SJ.

BMJ Open. 2019 Sep 24;9(9):e029538. doi: 10.1136/bmjopen-2019-029538.

12.

A novel nano-iron supplement to safely combat iron deficiency and anaemia in young children: The IHAT-GUT double-blind, randomised, placebo-controlled trial protocol.

Pereira DIA, Mohammed NI, Ofordile O, Camara F, Baldeh B, Mendy T, Sanyang C, Jallow AT, Hossain I, Wason J, Prentice AM.

Version 2. Gates Open Res. 2018 Oct 11 [revised 2018 Jan 1];2:48. doi: 10.12688/gatesopenres.12866.2. eCollection 2018.

13.

Robust methods in Mendelian randomization via penalization of heterogeneous causal estimates.

Rees JMB, Wood AM, Dudbridge F, Burgess S.

PLoS One. 2019 Sep 23;14(9):e0222362. doi: 10.1371/journal.pone.0222362. eCollection 2019.

14.

Case-mix, care pathways, and outcomes in patients with traumatic brain injury in CENTER-TBI: a European prospective, multicentre, longitudinal, cohort study.

Steyerberg EW, Wiegers E, Sewalt C, Buki A, Citerio G, De Keyser V, Ercole A, Kunzmann K, Lanyon L, Lecky F, Lingsma H, Manley G, Nelson D, Peul W, Stocchetti N, von Steinbüchel N, Vande Vyvere T, Verheyden J, Wilson L, Maas AIR, Menon DK; CENTER-TBI Participants and Investigators.

Lancet Neurol. 2019 Oct;18(10):923-934. doi: 10.1016/S1474-4422(19)30232-7.

PMID:
31526754
15.

PRECISE: a domain adaptation approach to transfer predictors of drug response from pre-clinical models to tumors.

Mourragui S, Loog M, van de Wiel MA, Reinders MJT, Wessels LFA.

Bioinformatics. 2019 Jul 15;35(14):i510-i519. doi: 10.1093/bioinformatics/btz372.

16.

Author Correction: WWP2 regulates pathological cardiac fibrosis by modulating SMAD2 signaling.

Chen H, Moreno-Moral A, Pesce F, Devapragash N, Mancini M, Heng EL, Rotival M, Srivastava PK, Harmston N, Shkura K, Rackham OJL, Yu WP, Sun XM, Tee NGZ, Tan ELS, Barton PJR, Felkin LE, Lara-Pezzi E, Angelini G, Beltrami C, Pravenec M, Schafer S, Bottolo L, Hubner N, Emanueli C, Cook SA, Petretto E.

Nat Commun. 2019 Sep 9;10(1):4085. doi: 10.1038/s41467-019-12060-5.

17.

Health in the UK.

Bird SM.

Lancet. 2019 Sep 7;394(10201):827-828. doi: 10.1016/S0140-6736(19)31246-2. No abstract available.

PMID:
31498093
18.

Molecular Characterization of Locally Relapsed Head and Neck Cancer after Concomitant Chemoradiotherapy.

de Roest RH, Mes SW, Poell JB, Brink A, van de Wiel MA, Bloemena E, Thai E, Poli T, Leemans CR, Brakenhoff RH.

Clin Cancer Res. 2019 Aug 22. doi: 10.1158/1078-0432.CCR-19-0628. [Epub ahead of print]

PMID:
31439582
19.

May the odds be ever in your favour.

Bonnett LJ, White SR.

Teach Stat. 2018 Fall;40(3):94-97. doi: 10.1111/test.12162. Epub 2018 May 9.

20.

Improving Primary Care After Stroke (IPCAS) trial: protocol of a randomised controlled trial to evaluate a novel model of care for stroke survivors living in the community.

Mullis R, Aquino MRJR, Dawson SN, Johnson V, Jowett S, Kreit E, Mant J; IPCAS investigator team.

BMJ Open. 2019 Aug 18;9(8):e030285. doi: 10.1136/bmjopen-2019-030285.

Supplemental Content

Loading ...
Support Center